In 2011, Sanofi-Aventis, the world's fifth largest pharmaceutical company, decided to shorten the company's name as Sanofi, and launch a new logo at the same time. Ten years later, Sanofi rebranded his brand again and launched a brand new corporate image logo.
Sanofi is headquartered in Paris, France and is the fifth largest pharmaceutical company in the world. Dedicated to the research, development, production and sales of pharmaceutical products. The products mainly cover seven areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine diseases and vaccines.
Sanofi brand reinvented centers on a new, simple, lowercase logo with two purple dots at the beginning and end of its name. The bottom of the letter "S" was also deliberately cut off to show what the company said (at least an inverted question mark).
Sanofi said in a statement that the two purple dots "reflect the scientific journey between the starting point and the end point - that is, unlocking innovative solutions to influence the moments of people's lives." Additionally, the new logo is inspired by simple and movement-oriented code in the tech industry.
Sanofi's changes are not only the logo. More than a decade after acquiring American biotech company Genzyme, it now transfers its Sanofi Genzyme division to the Sanofi brand. The same goes for its older vaccine division, Sanofi Pasteur. All its other acquisitions will also use the new brand. Thinking and acting as a single entity under a new shared goal and identity will allow Sanofi to drive important innovations by more strategically applying the existing resources of the entire company to make greater impact. "Through our new brand, we strive to give our employees, partners, patients and healthcare professionals a clear and in-depth understanding of who we are and what we are going to achieve. We believe that our new brand and logo opens up a unique space in the healthcare industry, perfectly representing our new goal of pursuing scientific miracles to improve people's lives."
More than a year ago, Pfizer, a multinational pharmaceutical company in the United States, took a similar move, abandoning the old pill-based logo and switching to a two-color blue double helix and an updated font. The trademarks and images that appear in the
article belong to their legal holders and are for information transmission only and are not for commercial purposes. If you are unintentionally infringed on your rights, please contact us in time to deal with it.
